About | Free Trial

Last Update

2016-07-19T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Stephen Squinto?

Dr. Stephen Squinto P.

Director

audentes therapeutics, inc.

HQ Phone: (415) 872-7001

Email: s***@***.com

audentes therapeutics, inc.

101 Montgomery Street Suite 2650

San Francisco, California 94104

United States

Company Description

San Francisco-based Audentes Therapeutics, announced today that it will buy Cardiogen Sciences, Inc., headquartered in Palo Alto, Calif. Financial details were not disclosed. Audentes focuses on developing and commercializing adeno-associated virus (AAV... more

Find other employees at this company (53)

Background Information

Employment History

American College of Lifestyle Medicine

The Connecticut Hockey Conference

Chair Alexion

Venture Partner

OrbiMed Advisors LLC

Affiliations

EXECUTIVE BOARD Member
Lyfebulb Inc

Board Member
Arvinas Inc

Board Member
TherAchon AG

Board Member
New Haven Symphony Orchestra

Lyfebulb Executive Board Member
Social Club

Board of Directors of the Regional Chapter
JDRF

Board Member
Generation UCAN

Executive Vice President, Head of Research and Development
Alexion Pharmaceuticals Inc

Co-Founder
Enobia Pharma Inc.

Education

B.A.
Chemistry
Loyola University of Chicago

Ph.D.

Ph.D.
Biochemistry and Biophysics
Loyola University of Chicago

bachelor's degree
chemistry
Loyola University

doctorate degree
biochemistry and biophysics
Loyola University

Web References (172 Total References)


OrbiMed

www.orbimed.com [cached]

Audentes Therapeutics Appoints Stephen Squinto, Ph.D. to its Board of Directors


OrbiMed

www.orbimed.com [cached]

Audentes Therapeutics Appoints Stephen Squinto, Ph.D. to its Board of Directors


OrbiMed

www.orbimed.com [cached]

Audentes Therapeutics Appoints Stephen Squinto, Ph.D. to its Board of Directors


OrbiMed

www.orbimed.com [cached]

Audentes Therapeutics Appoints Stephen Squinto, Ph.D. to its Board of Directors


Stephen Squinto, ...

audentestx.com [cached]

Stephen Squinto, Ph.D.

Stephen Squinto, Ph.D., has over 25 years of experience in the biotechnology industry, as both a scientist and senior executive. He is currently a Venture Partner with OrbiMed. Dr. Squinto was a co-founder of Alexion Pharmaceuticals Inc. and recently served as its Executive Vice President and Chief Global Operations Officer. Prior to 2013, he was Alexion's Global Head of Research and Development. Alexion is dedicated to developing therapies for certain rare and ultra-rare diseases. From 1988 to 1992, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both the Tulane University and LSU Medical Schools. He is a recipient of numerous honors and awards from academic and professional organizations for his scientific work.
Dr. Squinto received his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola University of Chicago.

Similar Profiles

Other People with this Name

Other people with the name Squinto

Adam Squinto
The Madison Square Garden Company

Eric Squinto
Burst.com Inc.

Adam Squinto
Loyola University

Stephen Squinto
Mass High Tech

Stephen Squinto

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory